SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-19-000179
Filing Date
2019-01-18
Accepted
2019-01-18 16:34:47
Documents
5
Period of Report
2018-11-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A f8-ka.htm 8-K/A 36293
2 EX-23.1 ex-23d1.htm EX-23.1 3783
3 EX-23.2 ex-23d2.htm EX-23.2 193855
4 EX-99.2 ex-99d2.htm EX-99.2 268795
5 EX-99.3 ex-99d3.htm EX-99.3 659801
  Complete submission text file 0001558370-19-000179.txt   1163583
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37581 | Film No.: 19533538
SIC: 2834 Pharmaceutical Preparations